The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis

Endometriosis and infertility: pathophysiology and management

de Ziegler, D., Borghese, B., & Chapron, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60490-4 · Cited by 836 · see citing works

Therapeutic roles of peroxisome proliferator-activated receptor agonists

Staels, B., & Fruchart, J.-C. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2460 · Cited by 646 · see citing works

Cyclopentenone prostaglandins: New insights on biological activities and cellular targets

Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006 · Cited by 575 · see citing works

Cyclopentenone prostaglandins: New insights on biological activities and cellular targets

Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006.abs · Cited by 521 · see citing works

Cyclooxygenase-2 (COX-2)–Independent Anticarcinogenic Effects of Selective COX-2 Inhibitors

Grösch, S., Maier, T. J., Schiffmann, S., & Geißlinger, G. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj206 · Cited by 482 · see citing works

Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.

Leahy, K. M., Ornberg, R., Wang, Y., Zweifel, B. S., Koki, A. T., & Masferrer, J. L. (2002) · PubMed · Cited by 440 · see citing works

PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S. M., Duensing, S. M., Fletcher, C. D. �., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15634 · Cited by 349 · see citing works

Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis

Ota, H., Igarashi, S., Sasaki, M., & Tanaka, T. (2001) · Human Reproduction · doi:10.1093/humrep/16.3.561 · Cited by 301 · see citing works

PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Panigrahy, D., Singer, S., Shen, L. Q., Butterfield, C., Freedman, D. A., Chen, E. J., Moses, M. A., Kilroy, S. M., Duensing, S. M., Fletcher, C. D. �., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215634 · Cited by 276 · see citing works

Advances in the management of endometriosis: an update for clinicians

Crosignani, P., Olive, D., Bergqvist, A., & Luciano, A. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi049 · Cited by 237 · see citing works

Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis

Meresman, G. F., Vighi, S., Buquet, R. A., Ortiz, O. C., Tesone, M., & Rumi, L. S. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01522-3 · Cited by 213 · see citing works

Endometriosis: Treatment Strategies

VALLE, R. F., & Sciarra, J. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.026 · Cited by 150 · see citing works

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells

Basu, G. D., Pathangey, L. B., Tinder, T. L., Gendler, S. J., & Mukherjee, P. (2005) · Breast Cancer Research · doi:10.1186/bcr1019 · Cited by 144 · see citing works

Thiazolidinediones as anti-cancer agents.

Blanquicett, C., Roman, J., & Hart, C. M. (2008) · PubMed · Cited by 141 · see citing works

The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis

Cobellis, L., Razzi, S., Simone, S. D., Sartini, A., Fava, A., Danero, S., Gioffrè, W. R., Mazzini, M., & Petraglia, F. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.02.007 · Cited by 140 · see citing works

Prostaglandin E 2 : the master of endometriosis?

Wu, M., Lu, C.-W., Chuang, P., & Tsai, S. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009321 · Cited by 135 · see citing works

Effects of Rosiglitazone in Obese Women with Polycystic Ovary Syndrome and Severe Insulin Resistance

Sepilian, V., & Nagamani, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1376 · Cited by 130 · see citing works

Conventional Medical Therapies for Endometriosis

Rice, V. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02795.x · Cited by 127 · see citing works

Peroxisome proliferator–activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis

Lebovic, D. I., Kir, M., & Casey, C. L. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.148 · Cited by 127 · see citing works

Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis

Ricci, A. G., Olivares, C. N., Bilotas, M. A., Meresman, G. F., & Barañao, R. I. (2011) · Reproductive Sciences · doi:10.1177/1933719110395406 · Cited by 104 · see citing works

Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Gerstein, H. C., Ratner, R. E., Cannon, C. P., Serruys, P. W. J. C., Garcia-Garcia, H., van Es, G., Kolatkar, N. S., Kravitz, B. G., Miller, D. M., Huang, C., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.881003 · Cited by 102 · see citing works

Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium

Matsuzaki, S., Canis, M. J., Pouly, J. L., Wattiez, A., Okamura, K., & Mage, G. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.059 · Cited by 94 · see citing works

Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib

Doğan, E., Saygılı, U., Posacı, C., Tuna, B., Uysal, S., Altunyurt, S., & Saatli, B. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.06.033 · Cited by 85 · see citing works

Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats

Matsuzaki, S., Canis, M. J., Darcha, C., Dallel, R., Okamura, K., & Mage, G. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.946 · Cited by 83 · see citing works

PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: A prospective, randomized, placebo- and drug-controlled study

Lebovic, D. I., Mwenda, J. M., Chai, D. C., Mueller, M. D., Santi, A., Fisseha, S., & D’Hooghe, T. M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.072 · Cited by 79 · see citing works

A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice

Ozawa, Y., Murakami, T., Tamura, M., Terada, Y., Yaegashi, N., & Okamura, K. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.057 · Cited by 76 · see citing works

Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis

Olivares, C. N., Bilotas, M. A., Buquet, R. A., Borghi, M., Sueldo, C. E., Tesone, M., & Meresman, G. F. (2008) · Human Reproduction · doi:10.1093/humrep/den315 · Cited by 71 · see citing works

Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis

Bilotas, M. A., Meresman, G. F., Stella, I., Sueldo, C. E., & Barañao, R. I. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.08.058 · Cited by 67 · see citing works

Peroxisome proliferator-activated receptors and angiogenesis

Biscetti, F., Straface, G., Pitocco, D., Zaccardi, F., Ghirlanda, G., & Flex, A. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.04.011 · Cited by 65 · see citing works

Expression of cyclooxygenase‐2 and peroxisome proliferator‐activated receptor‐γ and levels of prostaglandin E2 and 15‐deoxy‐Δ12,14‐prostaglandin J2 in human breast cancer and metastasis

Badawi, A. F., & Badr, M. Z. (2002) · International Journal of Cancer · doi:10.1002/ijc.10770 · Cited by 60 · see citing works

Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor γ synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells

Sun, W., Chen, G., Ou, X., Yang, Y., Luo, C., Zhang, Y., Shao, Y., Xu, H., Xiao, B., Xue, Y.-P., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.023 · Cited by 60 · see citing works

Cardiovascular risk and thiazolidinediones—what do meta‐analyses really tell us?

Schernthaner, G.-H., & CHILTON, R. J. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01262.x · Cited by 57 · see citing works

The safety of thiazolidinediones

Tolman, K. G. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.534982 · Cited by 53 · see citing works

Peroxisome Proliferator-Activated Receptor-γ Receptor Ligand Partially Prevents the Development of Endometrial Explants in Baboons: A Prospective, Randomized, Placebo-Controlled Study

Lebovic, D. I., Mwenda, J. M., Chai, D. C., Santi, A., Xu, X., & D’Hooghe, T. M. (2010) · Endocrinology · doi:10.1210/en.2009-1076 · Cited by 48 · see citing works

Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens.

Brodie, A., Jelovac, D., & Long, B. J. (2003) · PubMed · Cited by 47 · see citing works

Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model

Demirtürk, F., Aytan, H., Caliskan, A. C., Aytan, P., & Köseoğlu, D. (2005) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2005.10.002 · Cited by 46 · see citing works

Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells

Wu, Y., & Guo, S. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.012 · Cited by 44 · see citing works

Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs

Peluffo, G., Stillitani, I., Rodríguez, V., Diament, M., & Klein, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20226 · Cited by 43 · see citing works

Thiazolidinediones as Therapy for Endometriosis: A Case Series

Moravek, M. B., Ward, E. A., & Lebovic, D. I. (2009) · Gynecologic and Obstetric Investigation · doi:10.1159/000230713 · Cited by 41 · see citing works

Potential use of COX-2–aromatase inhibitor combinations in breast cancer

Bundred, N. J., & Barnes, N. L. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602690 · Cited by 40 · see citing works

Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3

Magenta, G., Borenstein, X., Rolando, R., & Jasnis, M. A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-47 · Cited by 38 · see citing works

Emerging drugs in endometriosis

Mihalyi, A., Simsa, P., Kyama, C. M., Meuleman, C., Mwenda, J. M., & D’Hooghe, T. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.503 · Cited by 38 · see citing works

Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis

Herington, J. L., Crispens, M. A., Carvalho-Macedo, A. C., Camargos, A. F., Lebovic, D. I., Bruner‐Tran, K. L., & Osteen, K. G. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.09.017 · Cited by 38 · see citing works

Suppression of Tumor Formation by a Cyclooxygenase-2 Inhibitor and a Peroxisome Proliferator-Activated Receptor γ Agonist in an In vivo Mouse Model of Spontaneous Breast Cancer

Mustafa, A., & Kruger, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0958 · Cited by 38 · see citing works

Peroxisome proliferator‐activated receptor‐gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model

Aytan, H., CALISKAN, A. C., Demirtürk, F., Aytan, P., & Köseoğlu, D. (2007) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2007.00744.x · Cited by 34 · see citing works

The Role of PPAR‐γ and Its Interaction with COX‐2 in Pancreatic Cancer

Eibl, G. (2008) · PPAR Research · doi:10.1155/2008/326915 · Cited by 33 · see citing works

The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer

Hazra, S., Peebles, K. A., Sharma, S. P., Mao, J. T., & Dubinett, S. M. (2008) · PPAR Research · doi:10.1155/2008/790568 · Cited by 30 · see citing works

An in vivo murine model of rosiglitazone use in pregnancy

Klinkner, D. B., Lim, H. J., Strawn, E., Oldham, K. T., & Sander, T. L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.024 · Cited by 26 · see citing works

Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease

Saryusz‐Wolska, M., Szymańska‐Garbacz, E., Jabłkowski, M., Białkowska, J., Pawłowski, M., Kwiecińska, E., Omulecka, A., Borkowska, A., Ignaczak, A., Loba, J. M., et al. (2011) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1023 · Cited by 22 · see citing works

COX and PPAR

Eibl, G., Reber, H. A., Hines, O. J., & Go, V. L. W. (2004) · Pancreas · doi:10.1097/00006676-200411000-00002 · Cited by 12 · see citing works

The effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk

Yee, M., Pavitt, D. V., Dhanjil, S. K., Godsland, I. F., Richmond, W., & Johnston, D. G. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03089.x · Cited by 11 · see citing works

Thiazolidinediones inhibit the growth of PC12 cells both in vitro and in vivo

Kim, S. W., Choi, O. K., Chang, M. S., Shin, C. S., Park, K. S., & Kim, S. Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.035 · Cited by 11 · see citing works

Nitrate, nitrite and N‐nitroso compounds in human bladder cancer associated with schistosomiasis

Badawi, A. F. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000515)86:4 · Cited by 11 · see citing works

World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: II. Clinical and covariate phenotype data collection in endometriosis research

Vitonis, A. F., Vincent, K., Rahmioglu, N., Fassbender, A., Buck Louis, G. M., Hummelshoj, L., Giudice, L. C., Stratton, P., Adamson, G. D., Becker, C. M., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.1244 · Cited by 236 · see citing works

Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics

McKinnon, B. D., Kocbek, V., Nirgianakis, K., Bersinger, N. A., & Mueller, M. D. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv060 · Cited by 194 · see citing works

Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies

Lin, Y.-H., Chen, Y.-H., Chang, H.-Y., Au, H., Tzeng, C., & Huang, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082385 · Cited by 187 · see citing works

Pharmacologic therapies in endometriosis: a systematic review

Soares, S. R., Martínez‐Varea, A., Hidalgo‐Mora, J. J., & Pellicer, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1120 · Cited by 154 · see citing works

Anti-angiogenic treatment strategies for the therapy of endometriosis

Laschke, M. W., & Menger, M. D. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms026 · Cited by 151 · see citing works

Current and emerging treatment options for endometriosis

Ferrero, S., Evangelisti, G., & Barra, F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1494154 · Cited by 152 · see citing works

Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology

Malvezzi, H., Marengo, E. B., Podgaec, S., & Piccinato, C. D. A. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02471-0 · Cited by 110 · see citing works

Medical Treatments for Endometriosis-Associated Pelvic Pain

Zito, G., Luppi, S., Giolo, E., Martinelli, M., Venturin, I., Lorenzo, G. D., & Ricci, G. (2014) · BioMed Research International · doi:10.1155/2014/191967 · Cited by 94 · see citing works

Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis

Chung, M. S., & Han, S. J. (2022) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2022.856316 · Cited by 89 · see citing works

Activated AKT Pathway Promotes Establishment of Endometriosis

Kim, T. H., Yu, Y., Luo, L., Lydon, J. P., Jeong, J., & Kim, J. J. (2014) · Endocrinology · doi:10.1210/en.2013-1951 · Cited by 82 · see citing works

Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure

Zhao, M., Sun, Y., Fu, G., Du, Y., Chen, F., Yuan, H., Zheng, C., Zhang, X., & Hu, F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.077 · Cited by 69 · see citing works

New trends for the medical treatment of endometriosis

Rocha, A. L. L., Reis, F. M., & Petraglia, F. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.683783 · Cited by 60 · see citing works

Angiogenesis signaling in endometriosis: Molecules, diagnosis and treatment (Review)

Bo, C., & Wang, Y. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13167 · Cited by 65 · see citing works

Endometriosis, especially mild disease: a risk factor for miscarriages

Kohl Schwartz, A. S., Wölfler, M. M., Mitter, V., Rauchfuss, M., Haeberlin, F., Eberhard, M., von Orelli, S., Imthurn, B., Imesch, P., Fink, D., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.08.025 · Cited by 63 · see citing works

Investigational drugs for the treatment of endometriosis, an update on recent developments

Barra, F., Scala, C., Mais, V., Guerriero, S., & Ferrero, S. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1471135 · Cited by 57 · see citing works

Animal models for anti-angiogenic therapy in endometriosis

Edwards, A. K., Nakamura, D. S., Virani, S., Wessels, J. M., & Tayade, C. (2013) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.10.012 · Cited by 40 · see citing works

Anti‐Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms

Zheng, W., Cao, L., Xu, Z., Ma, Y., & Liang, X. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/4128984 · Cited by 37 · see citing works

Angiogenesis as a Therapeutic Target in Endometriosis

Djokovic, D., & Calhaz–Jorge, C. (2014) · Acta Médica Portuguesa · doi:10.20344/amp.5244 · Cited by 36 · see citing works

PPARγ Activation Inhibits Growth and Survival of Human Endometriotic Cells by Suppressing Estrogen Biosynthesis and PGE2 Signaling.

Lebovic, D. I., Kavoussi, S. K., Lee, J., Banu, S. K., & Arosh, J. A. (2013) · Endocrinology · doi:10.1210/en.2013-1168 · Cited by 36 · see citing works

New therapeutic approaches for endometriosis besides hormonal therapy

Chen, F.-Y., Wang, X., Tang, R.-Y., Guo, Z., Deng, Y.-Z.-J., & Yu, Q. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000569 · Cited by 35 · see citing works

The genetics and biochemistry of endometriosis

Burney, R. O. (2013) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3283630d56 · Cited by 34 · see citing works

Novel agents for the medical treatment of endometriosis

Platteeuw, L., & D’Hooghe, T. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000084 · Cited by 32 · see citing works

Targeting galectin‐1‐induced angiogenesis mitigates the severity of endometriosis

Bastón, J. I., Barañao, R. I., Ricci, A. G., Bilotas, M. A., Olivares, C. N., Singla, J. J., González, A. M., Stupirski, J. C., Croci, D. O., Rabinovich, G. A., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4397 · Cited by 32 · see citing works

Active compounds present inRosmarinus officinalis leaves andScutellaria baicalensis root evaluated as new therapeutic agents for endometriosis

Ferella, L., Bastón, J. I., Bilotas, M. A., Singla, J. J., González, A. M., Olivares, C. N., & Meresman, G. F. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.09.018 · Cited by 29 · see citing works

New treatment strategies and emerging drugs in endometriosis

Streuli, I., de Ziegler, D., Borghese, B., Santulli, P., Batteux, F., & Chapron, C. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.668885 · Cited by 27 · see citing works

Endometriosis: alternative methods of medical treatment

López, J. S. J., Muñoz-Hernando, L., Marques, L. M., Alvarez-Conejo, C., Tejerizo-García, A., González, G. L., Muñoz, E. V., Jiménez, Á. M., & Muñoz-González, J. L. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s78829 · Cited by 25 · see citing works

Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions

Olivares, C. N., Alaniz, L. D., Menger, M. D., Barañao, R. I., Laschke, M. W., & Meresman, G. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152302 · Cited by 28 · see citing works

Silymarin amplifies apoptosis in ectopic endometrial tissue in rats with endometriosis; implication on growth factor GDNF, ERK1/2 and Bcl-6b expression

Nahari, E., & Razi, M. (2018) · Acta Histochemica · doi:10.1016/j.acthis.2018.08.003 · Cited by 22 · see citing works

Animal models for research on endometriosis

Taniguchi, F., Wibisono, H., Khine, Y. M., & Harada, T. (2020) · Frontiers in Bioscience-Elite · doi:10.2741/871 · Cited by 22 · see citing works

Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model

Kim, Y., Kim, Y. J., Kim, M., Lee, S. J., Kwon, H., & Lee, J. H. (2020) · Biomedicines · doi:10.3390/biomedicines8120619 · Cited by 21 · see citing works

Possible effects of endometriosis-related immune events on reproductive function

Kökçü, A. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2767-2 · Cited by 20 · see citing works

PPARγ Agonists: Emergent Therapy in Endometriosis

Vallée, A., Vallée, J.-N., Blanche, A. F. L., & Lecarpentier, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14060543 · Cited by 19 · see citing works

Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions

Nenicu, A., Gu, Y. J., Körbel, C., Menger, M. D., & Laschke, M. W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13874 · Cited by 19 · see citing works

Role of medical treatment of endometriosis

Martone, S., Troìa, L., Marcolongo, P., & Luisi, S. V. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04784-5 · Cited by 18 · see citing works

Challenges in the development of novel therapeutic strategies for treatment of endometriosis

Vanhie, A., Tomassetti, C., Peeraer, K., Meuleman, C., & D’Hooghe, T. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1118461 · Cited by 17 · see citing works

Comprehensive characterization of endometrial competing endogenous RNA network in infertile women of childbearing age

Zhang, M., Li, J., Duan, S., Fang, Z., Tian, J., Yin, H., Zhai, Q., Wang, X., & Zhang, L. (2020) · Aging · doi:10.18632/aging.102874 · Cited by 17 · see citing works

Anastrozole and celecoxib for endometriosis treatment, good to keep them apart?

Olivares, C. N., Bilotas, M. A., Ricci, A. G., Barañao, R. I., & Meresman, G. F. (2012) · Reproduction · doi:10.1530/rep-12-0386 · Cited by 14 · see citing works

Rosiglitazone affects the progression of surgically‑induced endometriosis in a rat model

Zhang, S., Zhuang, L., Liu, Q., Yu, X., Min, Q., Chen, M., & Chen, Q. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11673 · Cited by 13 · see citing works

Inhibition of Cyclooxygenase-2 Suppresses the Recruitment of Endothelial Progenitor Cells in the Microvasculature of Endometriotic Lesions

Rudzitis‐Auth, J., Nickels, R. M., Menger, M. D., & Laschke, M. W. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.10.013 · Cited by 13 · see citing works

Effect of GuiXiong Xiaoyi Wan in Treatment of Endometriosis on Rats

Jin, Z., Wang, L., & Zhu, Z. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/208514 · Cited by 12 · see citing works

Catamenial Pneumothorax—Still an Unveiled Disease

Damps-Konstańska, I., Szukalska, A., Janowiak, P., & Jassem, E. (2024) · Medicina · doi:10.3390/medicina60122029 · Cited by 13 · see citing works

[Relevance of apoptosis in the female reproductive system].

Meresman, G. F. (2011) · PubMed · Cited by 11 · see citing works

Wenshen Xiaozheng Tang suppresses the growth of endometriosis with an antiangiogenic effect

Zhang, Z., Hu, C., Tang, W., Gui, T., Qian, R. Y., Xing, Y., Cao, P., & Wan, G. (2013) · Climacteric · doi:10.3109/13697137.2013.771331 · Cited by 11 · see citing works

An Update on Pathophysiology and Medical Management of Endometriosis

Kaur, K. K., & Allahbadia, G. (2016) · Advances in Reproductive Sciences · doi:10.4236/arsci.2016.42008 · Cited by 10 · see citing works

An overview of early drug development for endometriosis

Maggiore, U. L. R., & Ferrero, S. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1126579 · Cited by 10 · see citing works

Macrophage Phenotype Induced by Circulating Small Extracellular Vesicles from Women with Endometriosis

Martínez‐Zamora, M. Á., Armengol-Badia, O., Quintas, L., Carmona, F., & Closa, D. (2024) · Biomolecules · doi:10.3390/biom14070737 · Cited by 9 · see citing works

Experimental Treatments of Endometriosis

Attar, R., & Attar, E. (2015) · Women's Health · doi:10.2217/whe.15.51 · Cited by 6 · see citing works

Evaluation of peritoneal endometriosis treatment using intralesional acetylsalicylic acid injection in rabbits

Saad-Hossne, R., Barretto, A. B., Siqueira, J. M., & Denadai, R. (2016) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020160040000002 · Cited by 8 · see citing works

Inhibition of TP signaling promotes endometriosis growth and neovascularization

Furue, A., Hattori, K., Hosono, K., Tanabe, M., Sato, E., Honda, M., Sekiguchi, K., Ito, Y., Majima, M., Narumiya, S., et al. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13079 · Cited by 7 · see citing works

Integrative bioinformatics analysis of lipid metabolism-related genes and immune infiltration in endometriosis

Ye, X., Song, X., Zhou, S., Chen, G., & Wang, L. (2025) · Medicine · doi:10.1097/md.0000000000042816 · Cited by 7 · see citing works

The role of peroxisome proliferator-activated receptors in endometriosis

Psilopatis, I., Theocharis, S., & Beckmann, M. W. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1329406 · Cited by 8 · see citing works

Dose-Dependent Decreased Fertility in Response to the Burden of Endometriosis in a Murine Model

Rosa-e-Silva, A. C. J. S., Silva, J. C. R. E., Mamillapalli, R., & Taylor, H. S. (2019) · Reproductive Sciences · doi:10.1177/1933719119859438 · Cited by 8 · see citing works

Effect of urolithins A and B on ectopic endometrial growth in a murine model of endometriosis

Cormack, B. A. M., Olivares, C. N., Madanes, D., Ricci, A. G., Bilotas, M. A., & Barañao, R. I. (2021) · Food & Function · doi:10.1039/d1fo01702k · Cited by 5 · see citing works

Involvement of Prostaglandins in the Pathophysiology of Endometriosis

Gabriela, F., & Carla, N. (2012) · InTech eBooks · doi:10.5772/30414 · Cited by 5 · see citing works

Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis)

Azoulay, C., Bardy, C., Lasserre, M., & Brun, J.-L. (2018) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(18)88083-3 · Cited by 2 · see citing works

The effects of certain angioneogenesis inhibitors in experimental endometriosis in rats

Barbe, A. M., Berbets, A. M., DAVYDENKO, I. S., Yuzko, V., & Yuzko, O. M. (2019) · Cell and Organ Transplantology · doi:10.22494/cot.v7i2.101 · Cited by 2 · see citing works

Metabolic remodeling of endometriosis microenvironment: Energy stress and immune evasion

Yang, P., Wang, T., Liu, W., Miao, Y., Zhu, Y., & Sun, J. (2026) · iScience · doi:10.1016/j.isci.2026.116592 · Cited by 1 · see citing works

Endometriosis in Experimental Models

Taniguchi, F., & Harada, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54421-0_14 · Cited by 1 · see citing works

The efficacy of selective cyclooxygenase 2 inhibitors in the treatment of genital endometriosis

Samoshkin, N. G., Yarmolinskaya, M. I., & Polyakova, V. O. (2018) · Journal of obstetrics and women s diseases · doi:10.17816/jowd67252-60 · Cited by 1 · see citing works

Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis

Olivares, C. N. (2012) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)

Peptide inhibitors of angiogenesis in endometriosis and the female reproductive system

Edwards, A. K. (2014) · QSpace (Queen's University Library)

ОСОБЛИВОСТІ ЕКСПЕРИМЕНТАЛЬНОГО ЕНДОМЕТРІОЗУ ПРИ ЗАСТОСУВАННІ АГОНІСТА ДОФАМІНОВИХ РЕЦЕПТОРІВ

Barbe, A. M., Berbets, A. M., & Yuzko, O. M. (2019) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2019.v0.i2.10372

Endometriosis - Review Of Current Therapeutic Aproaches For Disease Control

Spasova, V., Karamisheva, V., Staneva, R., Hadjidekova, S. P., Antonova, O., Koleva, L., & Toncheva, D. I. (2019) · Annual for Hospital Pharmacy · doi:10.14748/ahp.v5i1.5971

Immunosuppression and immunotherapy in endometriosis

He, Y., Hung, S. W., Xu, H., & Wang, C. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820661-4.00001-7

Therapeutic Effect of Bromocriptine as a Dopamine Agonist on Endometrioma Size: A Double-Blind Randomized Controlled Trial

Poordast, T., Kandi, M. P. N., Kellaii, E. H. N., Askari, E., & Khalili, A. F. (2022) · International Journal of Women s Health and Reproduction Sciences · doi:10.15296/ijwhr.2023.27

Anastrozole and celecoxib for endometriosis treatment, good to keep them apart?

Olivares, C. N., Bilotas, M. A., Ricci, A. G., Barañao, R. I., & Meresman, G. F. (2012) · Reproduction · doi:10.1530/rep-12-0386 · Cited by 14 · see citing works

Inhibitory effect of rosiglitazone combined with cisplatin on the growth of endometrial carcinoma in Nude Mice

Wang, H. (2010)

Peroxisome proliferator‐activated receptor‐gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model

Aytan, H., CALISKAN, A. C., Demirtürk, F., Aytan, P., & Köseoğlu, D. (2007) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2007.00744.x · Cited by 34 · see citing works

Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model

Demirtürk, F., Aytan, H., Caliskan, A. C., Aytan, P., & Köseoğlu, D. (2005) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2005.10.002 · Cited by 46 · see citing works

Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis

Olivares, C. N., Bilotas, M. A., Buquet, R. A., Borghi, M., Sueldo, C. E., Tesone, M., & Meresman, G. F. (2008) · Human Reproduction · doi:10.1093/humrep/den315 · Cited by 71 · see citing works